期刊文献+

多发性骨髓瘤血、尿总轻链与游离轻链相符率比较及其临床意义 被引量:3

The comparison of accordant rate of total light chains and free light chains in serum and urine and its clinical significance of muitiple myeloma
原文传递
导出
摘要 目的:比较多发性骨髓瘤(MM)患者血总轻链和游离轻链相符率与尿总轻链和游离轻链相符率的差异性,探讨造成差异性的可能原因及其临床意义。方法检测128例 MM患者血、尿游离轻链和总轻链的浓度,分别统计计算血、尿总轻链和游离轻链的相符率并进行比较。结果128例 MM患者中有72例血总轻链和游离轻链变化完全相符,相符率为56.25%;有119例尿总轻链和游离轻链检测完全相符,相符率为92.97%,两者差异有统计学意义。结论血总轻链与血游离轻链检测相符率较低,尿总轻链与尿游离轻链相符率很高,因此在基层医院可以用尿总轻链替代尿游离轻链的检测。 Objective To compare the accordant rate of total light chains and free light chains in serum and urine of mutiple myeloma(MM)patients,and to discuss its clinical significance.Methods 128 MMpatients were included and detected for free and total light chains of serum and urine.Calculate and compare the accordant rates of free and total light chains in serum and urine respectively.Results Among the 128 MM patients,72 cases of serum free light chains(sFLCs)and serum total light chains (sTLCs)were accordant,the accordant rate was 56.25%.119 cases of urinary free light chains(uFLCs) and total light chains(uTLCs)were accordant,the accordant rate was 92.97%.There was a significant difference between the two groups.Conclusion In MM patients,the accordant rate of the TLC and FLC in serum is not high,nevertheless the accordant rate of the TLC and FLC in urine is very high.Therefore, the detection of uFLCs can be substituted by uTLCs in primary hospitals.
出处 《临床内科杂志》 CAS 2016年第4期243-245,共3页 Journal of Clinical Internal Medicine
基金 基金项目:湖北省自然科学基金资助项目(2011CDB211) 2012年第44批留学回国人员科研启动基金资助项目[教外司留(2012)940号]
关键词 多发性骨髓瘤 游离轻链 总轻链 相符率 Multiple myeloma Free Light Chain Total Light Chain Accordant rate
  • 相关文献

参考文献11

  • 1侯健.李建勇,邱录贵.主编.多发性骨髓瘤[M].第1版.上海科学技术出版社.2011,22-23.
  • 2Lachmann H J, GaUimore R, Gillmore JD, eta]. Outcomes in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy [ J ]. Br J Haema- to1,2003,122( 1 ) :78-84.
  • 3BradweU AR, Cart-Smith HD, Mead GP, et al. Serum test for assessment of patients with Benee Jones myeloma [ J ]. Lancet, 2003,361 ( 9356 ) : 489-491.
  • 4Drayson MT, Tang LX, Drew R, et al. Serum free light-chain measure- ments for identifying and monitoring patients with nonsecretory multiple myeloma[ J ]. Blood ,2001,97 (9) :2900-2902.
  • 5Martinez-Lopez J, Paiva B, Lopez-Anglada L. Critical analysis of the stringent complete response in multiple myeloma:contribution of sFLC and bone marrow clonality[ J ]. Blood ,2015,126 (7) : 858-862.
  • 6BradweU AR. Serum free light chain measurements move to center stage [J]. Clin Chem ,2005 ,51 (5) :805-807.
  • 7Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma Leukemia, 2006, 20 (9): 1467-1473.
  • 8Erdem BK, Davran F, Yilmaz VT, et al. The association of serum-free light-chain levels with markers of renal function [ J]. Ren Fail ,2015,37 (6) :1057-1060.
  • 9i Marien G, Oris E, Bradwell AR, et al. Detection of monoclonal proteins in sera by capillary zone electrophoresis and free light chain measure- ments [ J ]. Clin Chem,2002,48 (9) : 1600-1601.
  • 10Bradwell AR. Serum Free Light Chain Analysis[ M]. 2nd ed. Birming- ham :The Binding Site ltd. 2004,87-95.

同被引文献12

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部